Howard Benjamin Insider Trading $RGEN REPLIGEN CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Howard Benjamin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Howard Benjamin. Howard Benjamin is VP Business Development in REPLIGEN CORP ($RGEN).
Howard Benjamin in REPLIGEN CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Howard Benjamin: VP Business Development
Holdings: 43,851 shares
Current Value: $1,282,203
Latest Transaction: Nov 12 2014
$RGEN Market Capitalization: $984.14M
$RGEN Previous Close: $29.24
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Howard Benjamin in REPLIGEN CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 12 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Sell | S | 23.56 | 30,000 | 706,800 | 43,851 | 73.9 K to 43.9 K (-40.62 %) |
| Aug 14 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | M | 3.33 | 5,000 | 16,650 | 5,000 | |
| Aug 14 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Sell | S | 20.34 | 40,000 | 813,792 | 73,851 | 113.9 K to 73.9 K (-35.13 %) |
| Aug 14 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Buy | M | 3.33 | 5,000 | 16,650 | 113,851 | 108.9 K to 113.9 K (+4.59 %) |
| Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | M | 6.23 | 10,000 | 62,300 | 30,000 | |
| Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | M | 3.33 | 5,000 | 16,650 | 10,000 | |
| Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | M | 4.25 | 87,036 | 369,903 | 0 | |
| Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Payment of Exercise | F | 20.30 | 3,069 | 62,301 | 108,851 | 111.9 K to 108.9 K (-2.74 %) |
| Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Buy | M | 6.23 | 10,000 | 62,300 | 111,920 | 101.9 K to 111.9 K (+9.81 %) |
| Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Payment of Exercise | F | 20.30 | 820 | 16,646 | 101,920 | 102.7 K to 101.9 K (-0.80 %) |
| Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Buy | M | 3.33 | 5,000 | 16,650 | 102,740 | 97.7 K to 102.7 K (+5.12 %) |
| Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Payment of Exercise | F | 20.30 | 18,222 | 369,907 | 97,740 | 116 K to 97.7 K (-15.71 %) |
| Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Buy | M | 4.25 | 87,036 | 369,903 | 115,962 | 28.9 K to 116 K (+300.89 %) |
| Mar 03 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | A | 15.91 | 11,421 | 181,708 | 11,421 | |
| Mar 03 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Grant | A | 0.00 | 5,962 | 0 | 28,926 | 23 K to 28.9 K (+25.96 %) |
| May 07 2013 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | M | 3.33 | 10,000 | 33,300 | 142,036 | |
| May 07 2013 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | M | 4.25 | 12,964 | 55,097 | 152,036 | |
| May 07 2013 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Payment of Exercise | F | 8.84 | 3,767 | 33,300 | 22,964 | 26.7 K to 23 K (-14.09 %) |
| May 07 2013 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Buy | M | 3.33 | 10,000 | 33,300 | 26,731 | 16.7 K to 26.7 K (+59.77 %) |
| May 07 2013 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Payment of Exercise | F | 8.84 | 6,233 | 55,100 | 16,731 | 23 K to 16.7 K (-27.14 %) |
| May 07 2013 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Buy | M | 4.25 | 12,964 | 55,097 | 22,964 | 10 K to 23 K (+129.64 %) |
| Mar 12 2013 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | A | 6.23 | 40,000 | 249,200 | 165,000 |
Page: 1